Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Collection of Long-Term Outcome Data for Subjects Who Have Previously Participated in Selected Ipilimumab (MDX-010) Studies in Metastatic Melanoma

NCT00928031 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT00928031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00928031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Collection of Long-Term Outcome Data for Subjects Who Have Previously Participated in Selected Ipilimumab (MDX-010) Studies in Metastatic Melanoma
Lead sponsor
Bristol-Myers Squibb
Phase
Observational
Overall status
Completed
Start date
June 30, 2007
Completion date
April 30, 2009
Enrollment
160 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma